<DOC>
	<DOCNO>NCT01499225</DOCNO>
	<brief_summary>This study design evaluate efficacy safety YH14642 Korea patient chronic periodontitis , order investigate recommend therapeutic dose .</brief_summary>
	<brief_title>A Clinical Trial YH14642 Patients With Chronic Periodontal Disease</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Subjects must 20 year age old Have least 18 natural teeth Four clinical attachment level ( CAL ) ≥ 3mm Four periodontal pocket probe depth ( PD ) ≥ 4mm Have Bleeding probe Provide inform consent willingness cooperate study protocol Forbidden History Panax Notoginseng Rehmanniae Radix Preparata Hypersensitivity Doxycycline Hypersensitivity Zea mays L. extract Critical disease HIV previous three year Patients mental retardation dementia Systemic diseases diabetes hypertension Patients take Anticoagulants Antiplatelet Agents Patients malignant tumor Smoker Continually use 2weeks phenytoin , calcium channel blocker , cyclosporin , coumarin , nonsteroidal antiinflammatory drug aspirin use previous one month Patients need malignant tumor Patients receive periodontal treatment within last 6 month Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>